Contact Us


830 Corridor Park Boulevard, Suite 400
Knoxville, TN 37932
(844) 658-5745

I am a

Would you prefer to chat by

What would you like to discuss?

13 + 10 =

Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.

Please direct all inquiries to for immediate review.

Click Here for CDC recommendations for Identifying Monkeypox.

FDA Authorization Letter   |   FDA EUA Summary

CARES Act Statement